Current Challenges and New Opportunities for Gene-Environment Interaction Studies of Complex Diseases.

TitleCurrent Challenges and New Opportunities for Gene-Environment Interaction Studies of Complex Diseases.
Publication TypeJournal Article
Year of Publication2017
AuthorsMcAllister, K, Mechanic, LE, Amos, C, Aschard, H, Blair, IA, Chatterjee, N, Conti, D, W Gauderman, J, Hsu, L, Hutter, CM, Jankowska, MM, Kerr, J, Kraft, P, Montgomery, SB, Mukherjee, B, Papanicolaou, GJ, Patel, CJ, Ritchie, MD, Ritz, BR, Thomas, DC, Wei, P, Witte, JS
JournalAm J Epidemiol
Volume186
Issue7
Pagination753-761
Date Published2017 Oct 01
ISSN1476-6256
KeywordsDisease, Gene-Environment Interaction, Genetic Predisposition to Disease, Genome-Wide Association Study, High-Throughput Nucleotide Sequencing, Humans, Software
Abstract

Recently, many new approaches, study designs, and statistical and analytical methods have emerged for studying gene-environment interactions (G×Es) in large-scale studies of human populations. There are opportunities in this field, particularly with respect to the incorporation of -omics and next-generation sequencing data and continual improvement in measures of environmental exposures implicated in complex disease outcomes. In a workshop called "Current Challenges and New Opportunities for Gene-Environment Interaction Studies of Complex Diseases," held October 17-18, 2014, by the National Institute of Environmental Health Sciences and the National Cancer Institute in conjunction with the annual American Society of Human Genetics meeting, participants explored new approaches and tools that have been developed in recent years for G×E discovery. This paper highlights current and critical issues and themes in G×E research that need additional consideration, including the improved data analytical methods, environmental exposure assessment, and incorporation of functional data and annotations.

DOI10.1093/aje/kwx227
Alternate JournalAm J Epidemiol
PubMed ID28978193
PubMed Central IDPMC5860428
Grant ListU24 OD023382 / OD / NIH HHS / United States
U19 CA203654 / CA / NCI NIH HHS / United States
R01 CA195789 / CA / NCI NIH HHS / United States
R21 ES025052 / ES / NIEHS NIH HHS / United States
R01 CA189532 / CA / NCI NIH HHS / United States
R01 CA169122 / CA / NCI NIH HHS / United States
U01 HG009080 / HG / NHGRI NIH HHS / United States
U01 CA196386 / CA / NCI NIH HHS / United States
R01 MD010443 / MD / NIMHD NIH HHS / United States
P30 ES007048 / ES / NIEHS NIH HHS / United States
R35 CA197449 / CA / NCI NIH HHS / United States
R01 CA140561 / CA / NCI NIH HHS / United States
R01 HL116720 / HL / NHLBI NIH HHS / United States
R21 ES024844 / ES / NIEHS NIH HHS / United States
U01 HG009088 / HG / NHGRI NIH HHS / United States